Smith Gregory L, an insider at Medtronic PLC (MDT), sold 46,016 shares of the company's stock at a price of $102.08 per share on November 18, 2025. The total value of this transaction amounted to $4.70 million. Following this sale, Smith retains a holding of 46,016 shares in Medtronic.
Medtronic, a prominent player in the health care industry, engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company's diverse product offerings include advanced surgical technology, cardiac rhythm management, and various other medical devices and solutions.
This insider transaction underscores the transparency required by the SEC for such activities, providing investors with insight into executive actions regarding company stock. While insider selling can occur for numerous reasons, including diversification and personal financial needs, it does not inherently indicate a negative outlook on the company. Investors are advised to consider insider transactions as part of a broader analysis, examining patterns across multiple insiders and time periods rather than isolated events.
Medtronic's financial snapshot reveals a market capitalization of $128.7 billion, a P/E ratio of 27.62, and an EPS of 3.62. The company is expected to report earnings on February 17, 2026, with an estimated EPS of $1.35 and revenue of $9.0 billion.